Extrastriatal Mean Regional Uptake of Fluorine-18-FDOPA in the Normal Aged Brain—An Approach Using MRI-Aided Spatial Normalization
暂无分享,去创建一个
Takeo Ishigaki | Akinori Nakamura | Takashi Kato | Kengo Ito | Teruhiko Kachi | Yutaka Arahata | Yuji Abe | Takako Yamada | Yasuhiro Kawasumi | A. Nakamura | Takako Yamada | Takashi Kato | Kengo Ito | Y. Abe | T. Kachi | T. Ishigaki | Y. Arahata | Y. Kawasumi | Atsuko S. Nagano | Kentaro Hatano | K. Hatano
[1] R A Robb,et al. A software system for interactive and quantitative visualization of multidimensional biomedical images. , 1991, Australasian physical & engineering sciences in medicine.
[2] Alan C. Evans,et al. Regional striatal DOPA transport and decarboxylase activity in Parkinson's disease. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[3] Karl J. Friston,et al. Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson’s disease , 1999, Journal of neurology, neurosurgery, and psychiatry.
[4] M. Senda,et al. Electrophilic synthesis of 6-[18F]fluoro-L-DOPA : use of 4-O-pivaloyl-L-DOPA as a suitable precursor for routine production , 1993 .
[5] M. Torrens. Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268 , 1990 .
[6] K. Jellinger,et al. Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway. , 1991, Molecular and chemical neuropathology.
[7] C D Marsden,et al. Differing patterns of striatal 18F‐dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy , 1990, Annals of neurology.
[8] W. Ammann,et al. Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue , 1997, Neurology.
[9] B. Bloch,et al. Aromatic l-amino-acid decarboxylase (DOPA decarboxylase) gene expression in dopaminergic and serotoninergic cells of the rat brainstem , 1991, Neuroscience Letters.
[10] Y. Agid,et al. Dopamine deficiency in the cerebral cortex in Parkinson disease , 1982, Neurology.
[11] C. Marsden. Parkinson's disease , 1940, The Lancet.
[12] N. Ogawa. Molecular and chemical neuropharmacology of dopamine receptor subtypes. , 1995, Acta medica Okayama.
[13] S. Kish,et al. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. , 1988, The New England journal of medicine.
[14] C. Nahmias,et al. Dopamine visualized in the basal ganglia of living man , 1983, Nature.
[15] C. Patlak,et al. Nigrostriatal function in humans studied with positron emission tomography , 1989, Annals of neurology.
[16] D. Brooks,et al. A PET study of voluntary movement in schizophrenic patients experiencing passivity phenomena (delusions of alien control). , 1997, Brain : a journal of neurology.
[17] K. Jellinger,et al. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. , 1973, Journal of the neurological sciences.
[18] T Jones,et al. The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease. , 1990, Archives of neurology.
[19] C S Patlak,et al. Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[20] K Wienhard,et al. Functional effects of striatal dysfunction in Parkinson disease. , 1997, Archives of neurology.
[21] Karl J. Friston,et al. Cortical grey matter and benzodiazepine receptors in malformations of cortical development. A voxel-based comparison of structural and functional imaging data. , 1997, Brain : a journal of neurology.
[22] V. Dhawan,et al. Input functions for 6-[fluorine-18]fluorodopa quantitation in parkinsonism: comparative studies and clinical correlations. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[23] A. Lees,et al. Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.
[24] C. Nahmias,et al. The Distribution and Kinetics of [18F]6-Fluoro-3-O-Methyl-l-Dopa in the Human Brain , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[25] T. Ishikawa,et al. Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[26] J. Mazziotta,et al. MRI‐PET Registration with Automated Algorithm , 1993, Journal of computer assisted tomography.
[27] Karl J. Friston,et al. Human Brain Function , 1997 .
[28] J C Mazziotta,et al. The effects of carbidopa administration on 6-[18F]fluoro-L-dopa kinetics in positron emission tomography. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[29] Christian Degueldre,et al. Functional Neuroanatomy of Human Slow Wave Sleep , 1997, The Journal of Neuroscience.
[30] E. Marder. Neurotransmitters and Neuromodulators , 1987 .
[31] V J Cunningham,et al. 11C-Diprenorphine Binding in Huntington's Disease: A Comparison of Region of Interest Analysis with Statistical Parametric Mapping , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[32] C. Patlak,et al. Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. Generalizations , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[33] H. Kimura,et al. Human positron emission tomographic [18F]Fluorodopa studies correlate with dopamine cell counts and levels , 1993, Annals of neurology.
[34] D. Weinberger,et al. Dopamine, the prefrontal cortex and schizophrenia , 1997, Journal of psychopharmacology.
[35] J. Mazziotta,et al. Rapid Automated Algorithm for Aligning and Reslicing PET Images , 1992, Journal of computer assisted tomography.
[36] J. Mendlewicz,et al. Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex , 1997, British Journal of Psychiatry.
[37] Monique Ernst,et al. DOPA Decarboxylase Activity in Attention Deficit Hyperactivity Disorder Adults. A [Fluorine-18]Fluorodopa Positron Emission Tomographic Study , 1998, The Journal of Neuroscience.